See also this year's filing and all EDGAR filings for this company.
PDF Report 0000835887_2020_Progenics_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000835887, Progenics Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 63,732,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 24,670,000 |
| 2 | PropertyPlantAndEquipmentNet | 11,688,000 |
| 3 | remainder_Assets | 19,380,000 |
| 4 | LiabilitiesCurrent | 22,068,000 |
| 5 | LiabilitiesNoncurrent | 46,915,000 |
| 6 | remainder_Liabilities | 3,934,000 |
| 7 | CostOfGoodsAndServicesSold | 3,168,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 50,777,861 |
| 9 | ResearchAndDevelopmentExpense | 47,439,120 |
| 10 | remainder_Expenses | 6,396,316 |
| 11 | remainder_Revenues | 28,485,571 |
| 12 | remainder_NetIncome | -2,486,537 |
| 13 | remainder_ComprehensiveNetIncome | -53,313 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 119,470,000 |
| 1 | Liabilities | 72,917,000 |
| 2 | Expenses | 107,781,297 |
| 3 | Revenues | 28,485,571 |
| 4 | StockholdersEquity | 46,553,000 |
| 5 | NetIncome | -81,782,263 |
| 6 | ComprehensiveNetIncome | -81,808,920 |
| 7 | BaseVar | 165,596,859 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.205 |
| 9 | EconomicCapitalRatio | 1.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
